We have highlighted the top five Nifty200 stocks with prices exceeding their book value, based on a valuation scan by Stockedge.com.
CDSL – Stock for our children (09-10-2024)
Quarterly update:
New invester and companies addition pace is accelerating with nearly 1.2 Crore investor accounts and almost 3500 new companies added during the quarter.
Expect reasonable growth in revenue and profits as compared to Q1.
AJ
Disclosure: Remain invested. Vews are biased.
These 4 stocks closed crossing above VWAP on October 8 (09-10-2024)
When the closing price rises above the VWAP, it signifies that the closing price is higher than the average price at which it was traded throughout the day, with the average being weighted by trading volume.
Natco Pharma: Focusing On Complex Products (09-10-2024)
Important thing to watch out is what are the terms of agreement between mylan and novo nordisk? By when (which year) natco can start selling ozempic? Natco still will have to get fda approval
Last time in dec 2015 when there was a out of court settlement by natco with bristol & myers for revlimid natco started selling revlimid in 2022 as the patent was expiring in jan 2026 natco got last 3 years of restricted volume exclusivity which means almost after 6 years natco started selling this drug post there mutual agreement…so we dont want such longer wait period…really hope that this time natco starts selling ozempic in next 2 yrs so that it can compensate revlimids sale post jan 2026
IRB Infra September toll collection jumps 19% YoY; share price up 3% (09-10-2024)
The uptick in IRB Infrastructure Developers share came on the back of strong toll revenue collection in September 2024.
Time To Avoid Stock Markets? (09-10-2024)
The narrative on China is changing post the recent stimulus measures, and it will be hard for global investors to ignore the Chinese markets.
Ajmera Realty gains after collections rise by 20% YoY in Q2 FY25 (09-10-2024)
Ajmera Realty & Infra India added 2.75% to Rs 650.95 after the company reported collections of Rs 133 crore in Q2 FY25, up by 20% from Rs 111 crore recorded in Q2 FY24.
Market drift higher; breadth strong (09-10-2024)
At 09:28 IST, the barometer index, the S&P BSE Sensex rose 136.92 points or 0.16% to 81,769.91. The Nifty 50 index added 46.90 points or 0.19% to 25,060.05.
Rupee finds breathing room as oil prices fall; RBI decision awaited (09-10-2024)
The Indian rupee slightly rose as oil prices declined and regional peers gained, ahead of the Reserve Bank of India’s monetary policy decision. Despite hovering near its record low, RBI interventions helped stabilize it. Traders focused on the expected unchanged policy rates but speculated on a possible shift in stance to neutral.